Compare HFFG & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HFFG | BHST |
|---|---|---|
| Founded | 1997 | 2007 |
| Country | United States | Canada |
| Employees | 960 | 87 |
| Industry | Food Distributors | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.7M | 97.7M |
| IPO Year | 2016 | N/A |
| Metric | HFFG | BHST |
|---|---|---|
| Price | $2.02 | $4.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $6.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 215.0K | 19.4K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.65 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,228,282,000.00 | N/A |
| Revenue This Year | $5.35 | $146.27 |
| Revenue Next Year | $2.47 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.21 | N/A |
| 52 Week Low | $1.38 | $4.10 |
| 52 Week High | $4.47 | $12.80 |
| Indicator | HFFG | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 57.23 | 43.51 |
| Support Level | $1.72 | $4.19 |
| Resistance Level | $2.34 | $4.96 |
| Average True Range (ATR) | 0.16 | 0.21 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 50.77 | 18.84 |
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.